Career history of William R. Shanahan
Former positions of William R. Shanahan
| Companies | Position | Start | End |
|---|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-08-14 | 2018-04-14 |
| ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2004-02-29 | 2016-06-12 |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Chief Tech/Sci/R&D Officer | 2000-07-31 | 2004-02-29 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 1994-09-30 | 2000-07-31 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 1989-12-31 | 1993-12-31 |
| Searle Research & Development | Chief Tech/Sci/R&D Officer | 1985-12-31 | 1988-12-31 |
| University of Connecticut | Corporate Officer/Principal | - | - |
Training of William R. Shanahan
| Dartmouth College | Undergraduate Degree |
| Loyola University of Chicago | Graduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistics
International
| United States | 11 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
| Searle Research & Development |
- Stock Market
- Insiders
- William R. Shanahan
- Experience
